1.
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
by Gold, Michael
Dementia and geriatric cognitive disorders, 2010, Vol.30 (2), p.131-146

2.
Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
by Rönnemaa, Elina
Dementia and geriatric cognitive disorders, 2011, Vol.31 (6), p.460-466

3.
Impact of SORL1 Single Nucleotide Polymorphisms on Alzheimer’s Disease Cerebrospinal Fluid Markers
by Alexopoulos, Panagiotis
Dementia and geriatric cognitive disorders, 2011, Vol.32 (3), p.164-170

4.
Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study
by Laitinen, M.H
Dementia and geriatric cognitive disorders, 2006, Vol.22 (1), p.99-107

5.
Associations of Blood Pressure with Functional and Cognitive Changes in Patients with Alzheimer's Disease
by de Oliveira, Fabricio Ferreira
Dementia and geriatric cognitive disorders, 2016, Vol.41 (5-6), p.314-323

6.
Type 2 Diabetes and Late-Onset Alzheimer’s Disease
by Cheng, D
Dementia and geriatric cognitive disorders, 2011, Vol.31 (6), p.424-430

7.
Volume Loss of the Medial Temporal Lobe Structures in Subjective Memory Impairment
by Striepens, Nadine
Dementia and geriatric cognitive disorders, 2010, Vol.29 (1), p.75-81

8.
Clinical Features of Rapidly Progressive Alzheimer’s Disease
by Schmidt, Christian
Dementia and geriatric cognitive disorders, 2010, Vol.29 (4), p.371-378

9.
Systemic Inflammation Is Associated with MCI and Its Subtypes: The Sydney Memory and Aging Study
by Trollor, Julian N
Dementia and geriatric cognitive disorders, 2011, Vol.30 (6), p.569-578

10.
Midlife Smoking, Apolipoprotein E and Risk of Dementia and Alzheimer’s Disease: A Population-Based Cardiovascular Risk Factors, Aging and Dementia Study
by Rusanen, M
Dementia and geriatric cognitive disorders, 2010, Vol.30 (3), p.277-284

11.
Aromatase Variants Modify Risk for Alzheimer's Disease in a Multiethnic Female Cohort
by Janicki, S.C
Dementia and geriatric cognitive disorders, 2013, Vol.35 (5-6), p.340-350

12.
Subgroups of Alzheimer's Disease Associated with Diabetes Mellitus Based on Brain Imaging
by Fukazawa, Raita
Dementia and geriatric cognitive disorders, 2013, Vol.35 (5-6), p.280-290

13.
IL-6–174 G/C and ApoE Gene Polymorphisms in Alzheimer’s and Vascular Dementia Patients Attending the Cognitive Disorder Clinic of the All India Institute of Medical Sciences, New D...
by Mansoori, Nasim
Dementia and geriatric cognitive disorders, 2011, Vol.30 (6), p.461-468

14.
Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease
by Ringman, John M
Dementia and geriatric cognitive disorders, 2012, Vol.33 (1), p.1-5

15.
Changes in Vascular Risk Factors from Midlife to Late Life and White Matter Lesions: A 20-Year Follow-Up Study
by Vuorinen, Miika
Dementia and geriatric cognitive disorders, 2011, Vol.31 (2), p.119-125

16.
Interethnic Differences in Dementia Epidemiology: Global and Asia-Pacific Perspectives
by Venketasubramanian, N
Dementia and geriatric cognitive disorders, 2011, Vol.30 (6), p.492-498

17.
Cognitive Impairment in Alzheimer’s Disease Is Modified by APOE Genotype
by van der Vlies, Annelies E
Dementia and geriatric cognitive disorders, 2007, Vol.24 (2), p.98-103

18.
Incidence and Risk Factors for Mild Cognitive Impairment: A Population-Based Three-Year Follow-Up Study of Cognitively Healthy Elderly Subjects
by Tervo, Susanna
Dementia and geriatric cognitive disorders, 2004, Vol.17 (3), p.196-203

19.
Progression from Amnesic Mild Cognitive Impairment to Alzheimer’s Disease: ESR1 and ESR2 Polymorphisms and APOE Gene
by Elcoroaristizabal Martín, X
Dementia and geriatric cognitive disorders, 2012, Vol.32 (5), p.332-341

20.
Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study
by Damian, Marinella
Dementia and geriatric cognitive disorders, 2013, Vol.36 (1-2), p.1-19
